Personally i reckon there are two groups of investors. Those...

Personally i reckon there are two groups of investors. Those that know all they need to know already about a company and make their decision based on research. The others, who i think are the majority of free traders appear to follow the crowd or those perceved to be "in the know". How else did pyc sell 200 million shares after the bog announcement. You can pass all the news you like but 70 % of available buyers will be looking around thinking no one important is buying. As soon as a broker or investment house or leading analyst starts to buy, and i mean buy not talk about it, the sheep and lemmings soon follow. The guys that bring sheep in need to be targetted and impressed to get things moving.

Just my opinion but i reckon if they go big on publicity about this new drug for cancer without futrther legitimste results they just reinforce the current market attitude that it sounds too good to be true.

If i had my choice i e ould cut all presemtations and travel for the next 6 months and spend that money inviting independent and respected scientists to view or use our technology -assuming we do actually have something remotely impressive. In reality the simple truth appears to be our director just told the market we can expect substantial costs for trials and no income for another 6 years. Given current performance by that time there will be 4 billion shares on offer.